A F EVERLAST WORLDWIDE BREAST CANCER RESEARCH EVERLAST WORLDWIDE BREAST CANCER RESEARCH
Everlast Worldwide partners with The Breast Cancer Research Foundation to donate 5% from sales of pink boxing gloves. (PRNewsFoto/Everlast Worldwide ...
NEW YORK, May 23 /PRNewswire-FirstCall/ -- Everlast Worldwide Inc.
(Nasdaq: EVST), manufacturer, marketer and licensor of sporting goods and
apparel under the Everlast brand name, today announced that it has
partnered with the Breast Cancer Research Foundation (BCRF) to champion a
critical fundraising effort for cancer research and prevention around the
world. The BCRF is an independent not-for-profit 501(c)(3) organization
founded by Evelyn H. Lauder in 1993 that is dedicated to preventing breast
cancer and finding a cure in our lifetime by funding clinical and genetic
research worldwide. Everlast will donate to the BCRF 5% from the sale of
every pair of its pink boxing gloves sold through sporting goods retailers
and on-line retailers across the country.
(Photo: http://www.newscom.com/cgi-bin/prnh/20060523/NYTU052 )
Seth Horowitz, Chairman, President and CEO of Everlast Worldwide Inc.,
said, "Since our earliest days as a licensee of women's activewear, we have
continually supported breast cancer research and awareness. This new effort
in conjunction with BCRF combines our interest in these causes and will
result in greater awareness for both while spurring financial
contributions. Breast cancer is a disease that affects so many, and the
Everlast family is committed to doing our part to raise funds and increase
public awareness. This is an example of our ongoing support of
philanthropic activities, which have included PE4LIFE and the American
To support this initiative, Everlast will launch a full-scale
cause-related marketing campaign to increase the awareness and funding of
breast cancer research, with ramped up efforts focused on National Breast
Cancer Awareness month in October. The campaign will involve partnerships
with major sporting goods retailers, women's health fitness centers,
athletes and print advertising.
Everlast will also develop an interactive on-line initiative through
its Web site as a meeting place to gain awareness about breast cancer, find
inspiring stories from other breast cancer survivors and promote BCRF and
Everlast's involvement. Additionally, Everlast will collaborate with Rock
and Sock Productions' "A Ring of Their Own" on a women's professional
boxing series that will be dedicated to increasing awareness for the cause,
with a planned pay-per-view event during National Breast Cancer Awareness
Myra Biblowit, President of the Breast Cancer Research Foundation,
said, "Research is advancing at an unprecedented pace, and the investments
that BCRF makes are having enormous impact on every continent. We welcome
Everlast into our family of partners and look forward to a fruitful
partnership. With the support of companies like Everlast, we are making
great strides to win."
About Everlast Worldwide Inc.
Everlast Worldwide Inc. manufactures, markets and licenses sporting
goods, apparel and active lifestyle products under the Everlast brand name.
Since 1910, Everlast has been the preeminent brand in the world of boxing
and is among the most dominant brands in the overall sporting goods and
apparel industries. Over the past 96 years, Everlast products have become
the "Choice of Champions(TM)", having been used for training and
professional fights by many of the biggest names in the sport. Everlast is
the market leader in nearly all of its product categories, responsible for
leading eight of the top ten boxing equipment products in sales. In
addition to producing and marketing boxing equipment and accessories,
Everlast Worldwide Inc. licenses its brand to providers of men's and
women's sportswear and active wear, children's wear, footwear, watches,
cardiovascular exercise equipment and gym/duffel bags. At the retail level,
Everlast's products generate over $700 million in revenues. The company's
Web site can be found at http://www.everlast.com .
About the Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) was founded in 1993 by
Evelyn H. Lauder as an independent, not-for-profit 501(c)(3) organization
dedicated to funding innovative clinical and genetic research. The
Foundation supports scientists at leading medical centers worldwide whose
research is focused on achieving prevention and a cure for breast cancer in
our lifetime. A minimum of 85 cents of each dollar donated to the
Foundation goes directly to breast cancer research and awareness programs.
In October 2005, $22 million was awarded to 110 researchers across the U.S.
and in Canada, Europe, Latin America and Israel. Money magazine named BCRF
one of America's eight top charities. The Foundation has received the
highest rating from Charity Navigator, four stars, for five consecutive
years, which means BCRF has outperformed most other charities in America in
efficiently managing its finances. For more information, visit
http://www.bcrfcure.org or call 1.866.FIND.A.CURE.
Statements made in this Press Release that are estimates of past or
future performance are based on a number of factors, some of which are
outside of the Company's control. Statements made in this Press Release
that state the intentions, beliefs, expectations or predictions of Everlast
Worldwide, Inc. and its management for the future are forward-looking
statements. It is important to note that actual results could differ
materially from those projected in such forward-looking statements.
Information concerning factors that could cause actual results to differ
materially from those in forward-looking statements is contained from time
to time in filings of Everlast Worldwide with the U.S. Securities and
Exchange Commission. Copies of these filings may be obtained by contacting
Everlast Worldwide or the SEC.
SOURCE Everlast Worldwide Inc.